论文部分内容阅读
目的:研究阿奇霉素治疗小儿支原体肺炎的临床效果。方法:对2009年1月-2010年11月我院入院治疗的132例小儿支原体肺炎患者进行了研究,随机分为两组,治疗组给药阿奇霉素,对照组给药红霉素,比较两组的治疗效果及临床不良反应。结果:治疗组治疗总有效率为93.9%,对照组总有效率为83.3%,两组比较差异明显,有统计学意义(P<0.05);对照组胃肠道反应等不良反应发生率明显高于治疗组,差异有统计学意义(P<0.05)。结论:阿奇霉素治疗小儿支原体肺炎临床疗效显著,不良反应少,好于第一代的红霉素,值得临床推广应用。
Objective: To study the clinical effect of azithromycin on mycoplasma pneumonia in children. Methods: 132 children with mycoplasma pneumonia admitted in our hospital from January 2009 to November 2010 were randomly divided into two groups: the treatment group was given azithromycin, the control group was given erythromycin, and the two groups were compared The treatment effect and clinical adverse reactions. Results: The total effective rate was 93.9% in the treatment group and 83.3% in the control group, with significant difference between the two groups (P <0.05). The incidence of gastrointestinal adverse reactions in the control group was significantly higher In the treatment group, the difference was statistically significant (P <0.05). Conclusion: The azithromycin treatment of children with mycoplasma pneumonia clinical significant effect, fewer adverse reactions, better than the first generation of erythromycin, worthy of clinical application.